These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15926798

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.
    Laufer SA, Domeyer DM, Scior TR, Albrecht W, Hauser DR.
    J Med Chem; 2005 Feb 10; 48(3):710-22. PubMed ID: 15689155
    [Abstract] [Full Text] [Related]

  • 4. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.
    Jahnke W, Blommers MJ, Fernández C, Zwingelstein C, Amstutz R.
    Chembiochem; 2005 Sep 10; 6(9):1607-10. PubMed ID: 16028302
    [No Abstract] [Full Text] [Related]

  • 5. kinDOCK: a tool for comparative docking of protein kinase ligands.
    Martin L, Catherinot V, Labesse G.
    Nucleic Acids Res; 2006 Jul 01; 34(Web Server issue):W325-9. PubMed ID: 16845019
    [Abstract] [Full Text] [Related]

  • 6. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
    Bao H, Kasten SA, Yan X, Roche TE.
    Biochemistry; 2004 Oct 26; 43(42):13432-41. PubMed ID: 15491150
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. NMR screening applied to the fragment-based generation of inhibitors of creatine kinase exploiting a new interaction proximate to the ATP binding site.
    Bretonnet AS, Jochum A, Walker O, Krimm I, Goekjian P, Marcillat O, Lancelin JM.
    J Med Chem; 2007 Apr 19; 50(8):1865-75. PubMed ID: 17375903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elucidation of characteristic structural features of ligand binding sites of protein kinases: a neural network approach.
    Niwa T.
    J Chem Inf Model; 2006 Apr 19; 46(5):2158-66. PubMed ID: 16995746
    [Abstract] [Full Text] [Related]

  • 18. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase.
    Viht K, Schweinsberg S, Lust M, Vaasa A, Raidaru G, Lavogina D, Uri A, Herberg FW.
    Anal Biochem; 2007 Mar 15; 362(2):268-77. PubMed ID: 17274940
    [Abstract] [Full Text] [Related]

  • 19. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
    Wen X, Yuan Y, Kuntz DA, Rose DR, Pinto BM.
    Biochemistry; 2005 May 10; 44(18):6729-37. PubMed ID: 15865418
    [Abstract] [Full Text] [Related]

  • 20. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors.
    Meyer B, Peters T.
    Angew Chem Int Ed Engl; 2003 Feb 24; 42(8):864-90. PubMed ID: 12596167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.